ロード中...
Anticoagulant Utilization and Direct Oral Anticoagulant Prescribing in Patients with Nonvalvular Atrial Fibrillation
BACKGROUND: Direct oral anticoagulants (DOACs) are indicated for prevention of stroke and embolism in patients with nonvalvular atrial fibrillation (NVAF). These agents have been shown to be non-inferior to warfarin in terms of efficacy and safety. However, their uptake in practice has been variable...
保存先:
| 出版年: | Can J Hosp Pharm |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Canadian Society of Hospital Pharmacists
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6910852/ https://ncbi.nlm.nih.gov/pubmed/31853143 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|